|
|
Article: Cochlear Americas Announces FDA Clearance For ESPrit(TM) 3G Behind The Ear Speech Processor; Designed to Help Cochlear Implant Recipients Hear More Clearly In All Environments.
- Article from:
- PR Newswire
- Article date:
- March 22, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER -- Cochlear Americas announced today that the U.S. Food and Drug Administration (FDA) cleared the ESPrit(TM) 3G behind the ear (BTE) speech processor for sale in the U.S. The ESPrit 3G is a breakthrough in performance, comfort, convenience and design for cochlear implant recipients. It is designed to help recipients hear clearly in all environments. The ESPrit 3G is compatible with all Nucleus(R) 24 cochlear implants, including the revolutionary Nucleus(R) 24 Contour(TM).
The ESPrit 3G is the only BTE in the cochlear implant industry to offer:
* A built-in telecoil that allows recipients wireless access to
hearing-aid compatible telephones. ...